Literature DB >> 27518621

Quantitative High-Throughput Luciferase Screening in Identifying CAR Modulators.

Caitlin Lynch1, Jinghua Zhao1, Hongbing Wang2, Menghang Xia3.   

Abstract

The constitutive androstane receptor (CAR, NR1I3) is responsible for the transcription of multiple drug metabolizing enzymes and transporters. There are two possible methods of activation for CAR, direct ligand binding and a ligand-independent method, which makes this a unique nuclear receptor. Both of these mechanisms require translocation of CAR from the cytoplasm into the nucleus. Interestingly, CAR is constitutively active in immortalized cell lines due to the basal nuclear location of this receptor. This creates an important challenge in most in vitro assay models because immortalized cells cannot be used without inhibiting the high basal activity. In this book chapter, we go into detail of how to perform quantitative high-throughput screens to identify hCAR1 modulators through the employment of a double stable cell line. Using this line, we are able to identify activators, as well as deactivators, of the challenging nuclear receptor, CAR.

Entities:  

Keywords:  Constitutive Androstane Receptor (CAR); Cytochrome P450 2B6 (CYP2B6); Luciferase; Quantitative high-throughput screening (qHTS)

Mesh:

Substances:

Year:  2016        PMID: 27518621      PMCID: PMC5341601          DOI: 10.1007/978-1-4939-6346-1_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

1.  Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands.

Authors:  L B Moore; D J Parks; S A Jones; R K Bledsoe; T G Consler; J B Stimmel; B Goodwin; C Liddle; S G Blanchard; T M Willson; J L Collins; S A Kliewer
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

2.  Differential effect of meclizine on the activity of human pregnane X receptor and constitutive androstane receptor.

Authors:  Aik Jiang Lau; Guixiang Yang; Ganesh Rajaraman; Christie C Baucom; Thomas K H Chang
Journal:  J Pharmacol Exp Ther       Date:  2010-12-02       Impact factor: 4.030

3.  Orphan nuclear receptor binding site in the human inducible nitric oxide synthase promoter mediates responsiveness to steroid and xenobiotic ligands.

Authors:  Andrea Toell; Klaus-Dietrich Kröncke; Hartmut Kleinert; Carsten Carlberg
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

4.  The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver.

Authors:  I Zelko; T Sueyoshi; T Kawamoto; R Moore; M Negishi
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

Review 5.  Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.

Authors:  Hongbing Wang; Edward L LeCluyse
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

6.  The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor.

Authors:  Linhao Li; Tao Chen; Joseph D Stanton; Tatsuya Sueyoshi; Masahiko Negishi; Hongbing Wang
Journal:  Mol Pharmacol       Date:  2008-05-20       Impact factor: 4.436

7.  Activation of the constitutive androstane receptor inhibits gluconeogenesis without affecting lipogenesis or fatty acid synthesis in human hepatocytes.

Authors:  Caitlin Lynch; Yongmei Pan; Linhao Li; Scott Heyward; Timothy Moeller; Peter W Swaan; Hongbing Wang
Journal:  Toxicol Appl Pharmacol       Date:  2014-05-27       Impact factor: 4.219

8.  Nuclear translocation of adenoviral-enhanced yellow fluorescent protein-tagged-human constitutive androstane receptor (hCAR): a novel tool for screening hCAR activators in human primary hepatocytes.

Authors:  Haishan Li; Tao Chen; John Cottrell; Hongbing Wang
Journal:  Drug Metab Dispos       Date:  2009-02-05       Impact factor: 3.922

9.  Quantitative high-throughput identification of drugs as modulators of human constitutive androstane receptor.

Authors:  Caitlin Lynch; Jinghua Zhao; Ruili Huang; Jingwei Xiao; Linhao Li; Scott Heyward; Menghang Xia; Hongbing Wang
Journal:  Sci Rep       Date:  2015-05-20       Impact factor: 4.379

10.  Identification of thyroid hormone receptor active compounds using a quantitative high-throughput screening platform.

Authors:  Jaime Freitas; Nicole Miller; Brenda J Mengeling; Menghang Xia; Ruili Huang; Keith Houck; Ivonne M C M Rietjens; J David Furlow; Albertinka J Murk
Journal:  Curr Chem Genom Transl Med       Date:  2014-03-07
View more
  2 in total

1.  Targeting CAR and Nrf2 improves cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatment.

Authors:  Sydney Stern; Dongdong Liang; Linhao Li; Ritika Kurian; Caitlin Lynch; Srilatha Sakamuru; Scott Heyward; Junran Zhang; Kafayat Ajoke Kareem; Young Wook Chun; Ruili Huang; Menghang Xia; Charles C Hong; Fengtian Xue; Hongbing Wang
Journal:  JCI Insight       Date:  2022-06-22

2.  Molecular Image-Based Prediction Models of Nuclear Receptor Agonists and Antagonists Using the DeepSnap-Deep Learning Approach with the Tox21 10K Library.

Authors:  Yasunari Matsuzaka; Yoshihiro Uesawa
Journal:  Molecules       Date:  2020-06-15       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.